GetPortalImpactFactorByIdResp(projectId=1, id=62fb12313, cover=https://img.medsci.cn/20231103/1698992110978_1614372.jpg, fullname=Therapeutic Advances in Neurological Disorders, abbr=THER ADV NEUROL DISO, pyear=2008, frequence=Bimonthly, articleNumbers=493, citedSelf2015=2.9, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.67月, reviewFee=0.0, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1756-2856, greenSci=https://www.greensci.net/search?kw=1756-2856, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-NEUROL-DISO.shtml, medsciHotlightString=null, medsciHotlightRealtime=5.511, medsciHotlight=3.679, medsciHotlight5year=2.61195, citescore=7.3, hIndex=50, impactFactor=5.9, orgnization=SAGE Publications Ltd, orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Clarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Scopus, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://journals.sagepub.com/home/TAN?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, websiteHits=3848, guideForAuthor=https://journals.sagepub.com/author-instructions/TAN?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, guideForAuthorHits=502, submitWebsite=https://mc.manuscriptcentral.com/tand?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, submitWebsiteHits=1729, content=<p>该刊是临床神经学领域领先的开放获取期刊，出版神经病学各个领域的前沿探索和创新研究。拥有超过一百万的年阅读量，是向全球发表您研究成果的首选平台。</p>, totalCites=2911, brief=THER ADV NEUROL DISO杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=临床神经病学" >临床神经病学</a></strong>”子行业的顶级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=THER ADV NEUROL DISO在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=62fb12313'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=2358, tagName=脑血管病, createdHits=1), ImpactFactorTagDto(id=1469, tagName=神经病学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.24), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.49), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.07), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=7.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.738), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=4.94), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=4.512), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.346), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=5.511)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Neurology (clinical) , rank=43/336), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=43/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Neuroscience - Neurology , rank=23/148)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-2856[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS[ta], article_number=57, article_number_cn=20, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)